| RS398123137 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Wilson disease |
| RS398123138 |
BTD
|
Health Risk |
Pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS398123139 |
BTD
|
Health Risk |
Pathogenic/Likely pathogenic |
Biotinidase deficiency, BTD-related disorder |
| RS398123140 |
BTD
|
Health Risk |
Likely pathogenic |
Biotinidase deficiency, Biotinidase deficiency |
| RS398123143 |
CAPN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS398123146 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS398123147 |
CAPN3
|
Health Risk |
Pathogenic |
— |
| RS398123149 |
CAPN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS398123150 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS398123151 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Homocystinuria |
| RS398123152 |
CDKN2A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS398123154 |
CPT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS398123155 |
EMD
|
Health Risk |
Pathogenic |
— |
| RS398123156 |
EMD
|
Health Risk |
Likely pathogenic |
— |
| RS398123157 |
EMD
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Emery-Dreifuss muscular dystrophy, X-linked Emery-Dreifuss muscular dystrophy |
| RS398123158 |
EMD
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Emery-Dreifuss muscular dystrophy, Emery-Dreifuss muscular dystrophy 1 |
| RS398123159 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS398123160 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary cancer-predisposing syndrome |
| RS398123161 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS398123162 |
FH
|
Health Risk |
Pathogenic |
— |
| RS398123163 |
FH
|
Health Risk |
Pathogenic |
Fumarase deficiency, Hereditary leiomyomatosis and renal cell cancer |
| RS398123164 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS398123165 |
FH
|
Health Risk |
Pathogenic |
— |
| RS398123166 |
FH
|
Health Risk |
Pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary cancer-predisposing syndrome |
| RS398123167 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS398123168 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Fumarase deficiency |
| RS398123169 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS398123170 |
GAA
|
Health Risk |
Pathogenic |
— |
| RS398123171 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS398123172 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS398123173 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS398123174 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS398123175 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS398123176 |
GALC
|
Health Risk |
Conflicting classifications of pathogenicity |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS398123177 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS398123179 |
GALT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Galactosemia |
| RS398123180 |
GALT
|
Health Risk |
Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS398123181 |
GALT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS398123182 |
GALT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS398123184 |
GALT
|
Health Risk |
Likely pathogenic |
GALT-related disorder, GALT-related disorder |
| RS398123185 |
GALT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS398123187 |
GALT
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS398123188 |
GALT
|
Health Risk |
Likely pathogenic |
— |
| RS398123190 |
GCDH
|
Health Risk |
Pathogenic/Likely pathogenic |
Glutaric aciduria, type 1 |
| RS398123191 |
GCDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutaric aciduria, type 1 |
| RS398123192 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS398123194 |
GCDH
|
Health Risk |
Pathogenic |
— |
| RS398123195 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS398123196 |
GK
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS398123197 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS398123198 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS398123199 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS398123200 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS398123201 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS398123202 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS398123203 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS398123204 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS398123205 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS398123206 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS398123207 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS398123208 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS398123209 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS398123210 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS398123211 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS398123212 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS398123213 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS398123214 |
GLA
|
Health Risk |
Pathogenic |
— |
| RS398123215 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, GLA-related disorder |
| RS398123216 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS398123217 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS398123218 |
GLA
|
Health Risk |
Pathogenic |
— |
| RS398123219 |
GLA
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Fabry disease |
| RS398123220 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS398123221 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS398123222 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS398123223 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS398123224 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS398123225 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS398123226 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS398123227 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS398123228 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS398123229 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS398123230 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome |
| RS398123231 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS398123232 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS398123234 |
GUSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS398123238 |
GUSB
|
Health Risk |
Pathogenic |
— |
| RS398123240 |
HPRT1
|
Health Risk |
Likely pathogenic |
Partial hypoxanthine-guanine phosphoribosyltransferase deficiency, Lesch-Nyhan syndrome |
| RS398123241 |
HPRT1
|
Health Risk |
Pathogenic |
Partial hypoxanthine-guanine phosphoribosyltransferase deficiency, Lesch-Nyhan syndrome |
| RS398123244 |
SGSH
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-A |
| RS398123246 |
SGSH
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-A |
| RS398123247 |
IDS
|
Health Risk |
Pathogenic |
— |
| RS398123248 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS398123249 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS398123250 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS398123251 |
IDS
|
Health Risk |
Pathogenic |
— |
| RS398123254 |
IDUA
|
Health Risk |
Likely pathogenic |
Hurler syndrome, Mucopolysaccharidosis |
| RS398123255 |
IDUA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |
| RS398123256 |
IDUA
|
Health Risk |
Pathogenic |
Hurler syndrome, Mucopolysaccharidosis type 1 |
| RS398123258 |
IDUA
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 1, Mucopolysaccharidosis type 1 |